Skip to content
Three pipettes with colored liquides, one is lifted up by a hand wearing blue gloves.

Up to two research calls per year

Research grants

Currently, the majority of our funding is awareded via research grants to academic institutions, although consortia including industry are welcome to apply.

Usually, two scheduled calls for research proposals are held each year. They can either be ‘All priorities’ calls which means that project topics should fit within one or more of EB-ResNet’s four strategic research priorities. Alternatively, a scheduled ‘Special’ call may be issued to invite proposals to address identified important unmet research questions, technology needs or clinical consequences arising from EB (e.g. chronic inflammation and fibrosis).

Project scope 'Research grants'

  • Fundamental to preclinical research, and clinical trials projects in EB
  • Research projects must fall into the scope of a current research call; either an 'All priorities' call or a 'Special call' i.e. chronical inflammationa and fibrosis
  • Lead applicant: researchers and/or clinicians (cooperation with industry welcome and possible)
  • Project duration: 12 to 36 months
  • Funding: up to EUR 100.000,00 p.a.

Note that the project leader must have a contract of employment with the lead host institution/organization at least for the time of the project period. Project lead salary and overheads/admin costs are not eligible. All research projects handed in have to be hypothesis driven and have to meet at least one of the EB-ResNet's research priorities. EB-ResNet is not supporting any service provision (i.e. clinical testing) costs.

For applications from research consortia involving industry, but led by an academic partner, additional side-agreements may be required. Please also note our terms & conditions including revenue sharing before submitting any application.

Funded projects

Grant Round/

Call

 

Project lead

Organisation/

Institute

Duration Research area EB-type Funder(s)
CIF Call 2018 Prof. Giovanna Zambruno

Bambino Gesu Ospedale,

Italy

3 years

Clinical research

RNA-therapy Fibrosis

Dystrophic

 

DEBRA Austria

DEBRA UK

DEBRA Spain

CIF Call 2018 Prof. Ulrich Rodeck

Thomas Jefferson University,

USA

2 years

Clinical researh

Small molecules

Fibrosis

Dystrophic

DEBRA Austria

DEBRA Ireland

CIF Call 2018 Dr. Yanling Liao

New York Medical College,

USA

3 years

Clinical research

Cancer

Dystrophic

DEBRA UK

DEBRA Ireland

All Priorities 2019 Prof. Valerie Brunton

University of Edinburgh,

UK

3 years

Fundamental research 

Cancer

Kindler

DEBRA Austria

DEBRA UK

All Priorities 2019 Prof. Karine Raymond

Leiden University Medical Center,

The Netherlands

3 years

Fundamental research

Pluripotent stem cells

Simplex

DEBRA Austria

All Priorities 2019 Dr. Colin Butler

University College London,

Great Ormond Street Institute

of Child Health,

UK

2 years

Fundamental research

Cellular and molecular therapy

Junctional

DEBRA Austria

DEBRA UK

All Priorities 2019 Prof. Liam Grover

University of Birmingham,

UK

2 years

Preclinical research

Small molecules

Dystrophic DEBRA UK

 

Grant Round/Call Project lead Organisation/Institute Duration Research area EB-type Funder(s)

Innovative Research

Grant Call 2017

Dr. Cédric Gaggioli

Projectdetails

Association pour le Développement

des Sciences Médicales,

Faculté de Médicine,

France

1 year

Fundamental research

Small molecules

Dystrophic DEBRA Austria

All Priorities

Call 2018

Prof. Jouni Uitto

Projectdetails

Thomas Jefferson University,

USA

2 years

Fundamental research

Molecular diagnostics

Dystrophic

Junctional

Simplex

DEBRA Austria

All Priorities

Call 2018

Prof. Ganna Bilousova

University of Colorado,

USA

3 years

Fundamental research

Cellular and molecular

therapy

Dystrophic DEBRA Austria

All Priorities

Call 2018

Dr. Su Lwin

Projectdetails

Kings College London,

UK

2 years

Gene therapy

SSC

Dystrophic DEBRA UK

All Priorities

Call 2018

Prof. Gareth Inman University of Glasgow 1 year SSC Dystrophic DEBRA UK

 

Grant Round/Call Project lead Organisation/Institute Duration Research area EB-type Funder(s)

All Priorities

Call 2017

Prof. Cristina Has

Projectdetails

University of Freiburg,

Germany

1 year

Fundamental research

Genetics

Simplex DEBRA Austria

All Priorities

Call 2017

Dr. Antonia Reimer

Projectdetails

University of Freiburg,

Germany

3 years

Fundamental research

Clinical characterization

Dystrophic

Junctional

DEBRA Austria

Innovative Research

Grant Call 2017

Prof. Margarita Calvo

Projectdetails

Pontificia Universidad

Católica de Chile,

Chile

1,5 years

Fundamental research

Small molecules

Symptom relief

Dystrophic

DEBRA Austria

 

All Priorities

Call 2017

Prof. Daniele Castiglia

Projectdetails

IRCCS, Rome,

Italy

3 years

Fundamental research

Small molecules

Woundhealing

Dystrophic DEBRA Austria

All Priorities

Call 2017

Prof. Thomas Magin

Projectdetails

University of Leipzig,

Germany

3 years

Fundamental research

Small molecules

Simplex DEBRA Austria

All Priorities

Call 2017

Prof. Alain Hovnanian

Projectdetails

INSERM, Departement of Genetics,

France

2 years

Fundamental research

Cellular and molecular

therapy

Dystrophic DEBRA Austria
CliniCall 2015 Prof. Peter Marinkovich Stanford University, USA 3 years

Clinical trial Phase II

Cellular and molecular

therapy

Dystrophic DEBRA Austria

 

Contact for Research grants

Portraitfoto von Gaston Sendin

Gaston Sendin, PhD.

Research Manager
Back to main navigation
This website uses cookies to give you the best possible service. By using this website, you agree to the use of cookies. Detailed information can be found in our privacy policy .